ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $267,000 | +2570.0% | 44,235 | +1910.7% | 0.01% | +900.0% |
| Q2 2017 | $10,000 | -73.7% | 2,200 | -75.8% | 0.00% | -75.0% |
| Q1 2017 | $38,000 | +58.3% | 9,100 | +203.3% | 0.00% | +33.3% |
| Q3 2016 | $24,000 | +200.0% | 3,000 | +20.0% | 0.00% | +200.0% |
| Q1 2014 | $8,000 | -96.1% | 2,500 | -96.3% | 0.00% | -96.9% |
| Q3 2013 | $203,000 | -80.0% | 67,300 | -45.9% | 0.03% | -85.3% |
| Q2 2013 | $1,017,000 | -10.2% | 124,332 | -3.9% | 0.22% | +3.3% |
| Q1 2013 | $1,132,000 | – | 129,332 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |